Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9 » default
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (3975)
- Volume 19, 2023 (118)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 9, 2013
Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients
Tanaka Y, Maruyama Y, Ishitobi Y, Kawano A, Ando T, Ikeda R, Inoue A, Imanaga J, Okamoto S, Kanehisa M, Ninomiya T, Tsuru J, Akiyoshi J
Neuropsychiatric Disease and Treatment 2013, 9:1899-1905
Published Date: 6 December 2013
Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
Takahashi N, Takahashi M, Saito T, Iizumi M, Saito Y, Shimizu H, Matsumura T
Neuropsychiatric Disease and Treatment 2013, 9:1889-1898
Published Date: 6 December 2013
Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas
Paiva WS, Fonoff ET, Marcolin MA, Bor-Seng-Shu E, Figueiredo EG, Teixeira MJ
Neuropsychiatric Disease and Treatment 2013, 9:1885-1888
Published Date: 9 December 2013
22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
Squarcione C, Torti MC, Di Fabio F, Biondi M
Neuropsychiatric Disease and Treatment 2013, 9:1873-1884
Published Date: 4 December 2013
Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study
Shimizu H, Takebayashi M, Tani M, Tanaka H, Yamagata B, Kurosawa K, Yamada H, Hachisu M, Hisaoka-Nakashima K, Okada-Tsuchioka M, Mimura M, Iwanami A
Neuropsychiatric Disease and Treatment 2013, 9:1867-1872
Published Date: 6 December 2013
Current clinical application of deep-brain stimulation for essential tremor
Chopra A, Klassen BT, Stead M
Neuropsychiatric Disease and Treatment 2013, 9:1859-1865
Published Date: 2 December 2013
Influence of cerebellar stereotactic stimulation on left–right electrodermal information transference in a patient with cerebral palsy
Bob P, Galanda T, Jombik P, Raboch J, Galanda M
Neuropsychiatric Disease and Treatment 2013, 9:1853-1858
Published Date: 29 November 2013
Olfactory functions are not associated with autism severity in autism spectrum disorders
Dudova I, Hrdlicka M
Neuropsychiatric Disease and Treatment 2013, 9:1847-1851
Published Date: 27 November 2013
Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases
Campanella S
Neuropsychiatric Disease and Treatment 2013, 9:1835-1845
Published Date: 28 November 2013
Adjunctive enteral phenobarbital for adult status epilepticus: a brief report
Tiamkao S, Suttapan K, Pranbul S, Tiamkao S, Sawanyawisuth K, Integrated Epilepsy Research group
Neuropsychiatric Disease and Treatment 2013, 9:1829-1834
Published Date: 26 November 2013
Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Pecenak J, Novotny V
Neuropsychiatric Disease and Treatment 2013, 9:1827-1828
Published Date: 26 November 2013
Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Abdel Hakeem NM, Abd Al Hamed M, Badry R
Neuropsychiatric Disease and Treatment 2013, 9:1821-1826
Published Date: 26 November 2013
Asperger syndrome related suicidal behavior: two case studies
Kocourkova J, Dudova I, Koutek J
Neuropsychiatric Disease and Treatment 2013, 9:1815-1819
Published Date: 22 November 2013
Duloxetine in panic disorder with somatic gastric pain
Preve M, Nisita C, Bellini M, Dell'Osso L
Neuropsychiatric Disease and Treatment 2013, 9:1811-1813
Published Date: 21 November 2013
Effectiveness and safety of Nintendo Wii Fit PlusTM training in children with migraine without aura: a preliminary study
Esposito M, Ruberto M, Gimigliano F, Marotta R, Gallai B, Parisi L, Lavano SM, Roccella M, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1803-1810
Published Date: 15 November 2013
Early resorption of an artificial bone graft made of calcium phosphate for cranioplasty: case report
Monaco BA, Fonoff ET, Teixeira MJ
Neuropsychiatric Disease and Treatment 2013, 9:1801-1802
Published Date: 15 November 2013
Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey
Yüce M, Zoroglu SS, Ceylan MF, Kandemir H, Karabekiroglu K
Neuropsychiatric Disease and Treatment 2013, 9:1791-1799
Published Date: 14 November 2013
Epidemiology of nonfatal stroke and transient ischemic attack in Al-Kharga District, New Valley, Egypt
Farghaly WM, El-Tallawy HN, Shehata GA, Rageh TA, Abdel-Hakeem NM, Elhamed MA, Al-Fawal BM, Badry R
Neuropsychiatric Disease and Treatment 2013, 9:1785-1790
Published Date: 18 November 2013
Brain volumes and neuropsychological performance are related to current smoking and alcoholism history
Luhar RB, Sawyer KS, Gravitz Z, Ruiz SM, Oscar-Berman M
Neuropsychiatric Disease and Treatment 2013, 9:1767-1784
Published Date: 12 November 2013
Effects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: a pilot study
Magalhães FNO, Soares SC, Torres JM, Ungaretti A, Cacciacarro MF, Teixeira MJ, Fonoff ET
Neuropsychiatric Disease and Treatment 2013, 9:1759-1766
Published Date: 12 November 2013
Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
Suttajit S, Paholpak S, Choovanicvong S, Kittiwattanagul K, Pratoomsri W, Srisurapanont M
Neuropsychiatric Disease and Treatment 2013, 9:1751-1757
Published Date: 11 November 2013
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses
Ciudad A, Anand E, Berggren L, Casillas M, Schacht A, Perrin E
Neuropsychiatric Disease and Treatment 2013, 9:1737-1750
Published Date: 8 November 2013
Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review
Beghi M, Rosenbaum JF, Cerri C, Cornaggia CM
Neuropsychiatric Disease and Treatment 2013, 9:1725-1736
Published Date: 8 November 2013
Quality of Web-based information on obsessive compulsive disorder
Klila H, Chatton A, Zermatten A, Khan R, Preisig M, Khazaal Y
Neuropsychiatric Disease and Treatment 2013, 9:1717-1723
Published Date: 5 November 2013
The role of the serotonergic system in suicidal behavior
Sadkowski M, Dennis B, Clayden RC, ElSheikh W, Rangarajan S, DeJesus J, Samaan Z
Neuropsychiatric Disease and Treatment 2013, 9:1699-1716
Published Date: 6 November 2013
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K
Neuropsychiatric Disease and Treatment 2013, 9:1683-1698
Published Date: 1 November 2013
Identification of common predictors of surgical outcomes for epilepsy surgery
Zhang J, Liu W, Chen H, Xia H, Zhou Z, Mei S, Liu Q, Li Y
Neuropsychiatric Disease and Treatment 2013, 9:1673-1682
Published Date: 6 November 2013
Sodium valproate-induced enuresis in a pediatric bipolar patient
Cheng W, Lin X, Lu D
Neuropsychiatric Disease and Treatment 2013, 9:1671-1672
Published Date: 31 October 2013
Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
Zou C, Ding X, Flaherty JH, Dong BR
Neuropsychiatric Disease and Treatment 2013, 9:1661-1670
Published Date: 1 November 2013
Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
Zhao Y, Kishi T, Iwata N, Ikeda M
Neuropsychiatric Disease and Treatment 2013, 9:1655-1659
Published Date: 29 October 2013
Cognitive functioning correlates of self-esteem and health locus of control in schizophrenia
Wang CS, Wu JYW, Chang WC, Chuang SP
Neuropsychiatric Disease and Treatment 2013, 9:1647-1654
Published Date: 29 October 2013
Let’s get back to work: survival analysis on the return-to-work after depression
Vemer P, Bouwmans CA, Zijlstra-Vlasveld MC, van der Feltz-Cornelis CM, Hakkaart-van Roijen L
Neuropsychiatric Disease and Treatment 2013, 9:1637-1645
Published Date: 25 October 2013
Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
Maynard SD, Gelblum J
Neuropsychiatric Disease and Treatment 2013, 9:1629-1635
Published Date: 23 October 2013
Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
Maynard SD, Gelblum J
Neuropsychiatric Disease and Treatment 2013, 9:1619-1627
Published Date: 23 October 2013
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
Bargiotas P, Konitsiotis S
Neuropsychiatric Disease and Treatment 2013, 9:1605-1617
Published Date: 22 October 2013
Agomelatine as monotherapy for major depression: an outpatient, open-label study
Pecenak J, Novotny V
Neuropsychiatric Disease and Treatment 2013, 9:1595-1604
Published Date: 22 October 2013
Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
Kitaichi Y, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, Koyama T
Neuropsychiatric Disease and Treatment 2013, 9:1591-1594
Published Date: 17 October 2013
Selective cognitive empathy deficit in adolescents with restrictive anorexia nervosa
Calderoni S, Fantozzi P, Maestro S, Brunori E, Narzisi A, Balboni G, Muratori F
Neuropsychiatric Disease and Treatment 2013, 9:1583-1589
Published Date: 16 October 2013
Evidence for single nucleotide polymorphisms and their association with bipolar disorder
Szczepankiewicz A
Neuropsychiatric Disease and Treatment 2013, 9:1573-1582
Published Date: 11 October 2013
Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
Yoshimura B, Hirota T, Takaki M, Kishi Y
Neuropsychiatric Disease and Treatment 2013, 9:1565-1571
Published Date: 10 October 2013
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M
Neuropsychiatric Disease and Treatment 2013, 9:1553-1564
Published Date: 11 October 2013
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2013, 9:1545-1552
Published Date: 11 October 2013
Spirituality in childhood cancer care
Lima NN, do Nascimento VB, de Carvalho SM, Neto ML, Moreira MM, Brasil AQ, Celestino Junior FT, de Oliveira GF, Reis AO
Neuropsychiatric Disease and Treatment 2013, 9:1539-1544
Published Date: 9 October 2013
Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
Ünsal C, Oran M, Tureli HO, Alpsoy S, Yeşilyurt S, Arslan M, Topcu B, Karakaya O, Kurt E
Neuropsychiatric Disease and Treatment 2013, 9:1531-1537
Published Date: 8 October 2013
Lurasidone as a potential therapy for bipolar disorder
Woo YS, Wang HR, Bahk WM
Neuropsychiatric Disease and Treatment 2013, 9:1521-1529
Published Date: 8 October 2013
Attachment styles in children affected by migraine without aura
Esposito M, Parisi L, Gallai B, Marotta R, Di Dona A, Lavano SM, Roccella M, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1513-1519
Published Date: 3 October 2013
Role of nucleus accumbens glutamatergic plasticity in drug addiction
Quintero GC
Neuropsychiatric Disease and Treatment 2013, 9:1499-1512
Published Date: 30 September 2013
Right putamen hemorrhage manifesting as apraxia of eyelid opening
Lin YH, Liou LM, Lai CL, Chang YP
Neuropsychiatric Disease and Treatment 2013, 9:1495-1497
Published Date: 26 September 2013
Younger age, female sex, and high number of awakenings and arousals predict fatigue in patients with sleep disorders: a retrospective polysomnographic observational study
Veauthier C
Neuropsychiatric Disease and Treatment 2013, 9:1483-1494
Published Date: 30 September 2013
Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care
Chien WT, Leung SF, Yeung FKK, Wong WK
Neuropsychiatric Disease and Treatment 2013, 9:1463-1481
Published Date: 25 September 2013
Persisting primitive reflexes in medication-naïve girls with attention-deficit and hyperactivity disorder
Konicarova J, Bob P, Raboch J
Neuropsychiatric Disease and Treatment 2013, 9:1457-1461
Published Date: 20 September 2013
Behavioral symptoms related to cognitive impairment
Dillon C, Serrano CM, Castro D, Pérez Leguizamón P, Heisecke SL, Taragano FE
Neuropsychiatric Disease and Treatment 2013, 9:1443-1455
Published Date: 19 September 2013
Psychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purpose
Esposito M, Gimigliano F, Ruberto M, Marotta R, Gallai B, Parisi L, Lavano SM, Mazzotta G, Roccella M, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1433-1441
Published Date: 19 September 2013
The Impact of Event Scale – Revised: psychometric properties of the Italian version in a sample of flood victims
Craparo G, Faraci P, Rotondo G, Gori A
Neuropsychiatric Disease and Treatment 2013, 9:1427-1432
Published Date: 19 September 2013
Childhood depression: a systematic review
Lima NNR, Nascimento VB, Carvalho SMF, Abreu LC, Neto MLR, Brasil AQ, Celestino Junior FT, Oliveira GF, Reis AOA
Neuropsychiatric Disease and Treatment 2013, 9:1417-1425
Published Date: 19 September 2013
Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
Kano O, Urita Y, Ito H, Takazawa T, Kawase Y, Murata K, Hirayama T, Miura K, Ishikawa Y, Kiyozuka T, Aoyagi J, Iwasaki Y
Neuropsychiatric Disease and Treatment 2013, 9:1411-1415
Published Date: 18 September 2013
Saccadic eye movement applications for psychiatric disorders
Bittencourt J, Velasques B, Teixeira S, Basile LF, Salles JI, Nardi AE, Budde H, Cagy M, Piedade R, Ribeiro P
Neuropsychiatric Disease and Treatment 2013, 9:1393-1409
Published Date: 16 September 2013
Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies
Gopal S, Liu Y, Alphs L, Savitz A, Nuamah I, Hough D
Neuropsychiatric Disease and Treatment 2013, 9:1381-1392
Published Date: 20 September 2013
Treatment of neurolept-induced tardive dyskinesia
Jankelowitz SK
Neuropsychiatric Disease and Treatment 2013, 9:1371-1380
Published Date: 16 September 2013
Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy
Shi Q, Warren L, Saposnik G, MacDermid JC
Neuropsychiatric Disease and Treatment 2013, 9:1359-1370
Published Date: 19 September 2013
Maternal personality profile of children affected by migraine
Esposito M, Roccella M, Gallai B, Parisi L, Lavano SM, Marotta R, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1351-1358
Published Date: 11 September 2013
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
Castrop F, Haslinger B, Hemmer B, Buck D
Neuropsychiatric Disease and Treatment 2013, 9:1339-1349
Published Date: 16 September 2013
Safety of escitalopram in pregnancy: a case series
Bellantuono C, Bozzi F, Orsolini L
Neuropsychiatric Disease and Treatment 2013, 9:1333-1337
Published Date: 9 September 2013
Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
Chien WT, Yip ALK
Neuropsychiatric Disease and Treatment 2013, 9:1311-1332
Published Date: 11 September 2013
Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test
Ogrim G, Hestad KA, Brunner JF, Kropotov J
Neuropsychiatric Disease and Treatment 2013, 9:1301-1309
Published Date: 5 September 2013
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects
El-Tallawy H, Farghaly W, Metwally N, Rageh T, Shehata GA, Badry R, El Moselhy E, Hassan M, Sayed MM, Abdelwarith AA, Hamed Y, Shaaban I, Mohamed T, Abd El Hamed M, Kandil MR
Neuropsychiatric Disease and Treatment 2013, 9:1295-1300
Published Date: 9 September 2013
Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s Republic of China
Zhang J, Xu CP, Wu HX, Xue XJ, Xu ZJ, Li Y, Gao Q, Liu QZ
Neuropsychiatric Disease and Treatment 2013, 9:1289-1294
Published Date: 2 September 2013
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
Suzuki H, Gen K
Neuropsychiatric Disease and Treatment 2013, 9:1281-1287
Published Date: 28 August 2013
The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
Koshino Y, Bahk WM, Sakai H, Kobayashi T
Neuropsychiatric Disease and Treatment 2013, 9:1273-1280
Published Date: 28 August 2013
Clozapine reinitiation following a "red result" secondary to chemotherapy
Munshi T, Mazhar M, Hassan T
Neuropsychiatric Disease and Treatment 2013, 9:1267-1271
Published Date: 27 August 2013
The use of psychotropic medication during pregnancy: how about the newborn?
Kieviet N, Dolman KM, Honig A
Neuropsychiatric Disease and Treatment 2013, 9:1257-1266
Published Date: 28 August 2013
Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
Leelahanaj T, Kongsakon R, Choovanichvong S, Tangwongchai S, Paholpak S, Kongsuk T, Srisurapanont M
Neuropsychiatric Disease and Treatment 2013, 9:1249-1256
Published Date: 22 August 2013
A discriminated conditioned punishment model of phobia
Bloom CM, Post RJ, Mazick J, Blumenthal B, Doyle C, Peters B, Dyche J, Davenport DG
Neuropsychiatric Disease and Treatment 2013, 9:1239-1248
Published Date: 21 August 2013
Occlusal traits in developmental dyslexia: a preliminary study
Perillo L, Esposito M, Contiello M, Lucchese A, Santini AC, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1231-1237
Published Date: 22 August 2013
An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients
Charnsil C, Vongpanich S
Neuropsychiatric Disease and Treatment 2013, 9:1223-1230
Published Date: 20 August 2013
Age as a factor in sensory integration function in Taiwanese children [Corrigendum]
Lin CK, Wu HM, Wang HY, Tseng MH, Lin CH
Neuropsychiatric Disease and Treatment 2013, 9:1221-1222
Published Date: 19 August 2013
Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s disease
Yang X, Wu N, Song L, Liu Z
Neuropsychiatric Disease and Treatment 2013, 9:1213-1220
Published Date: 19 August 2013
Celiac plexus neurolysis for the treatment of upper abdominal cancer pain
Teixeira MJ, Neto ER, Marinho da Nobrega JC, Angelos JS, Martin MS, Monaco BA, Fonoff ET
Neuropsychiatric Disease and Treatment 2013, 9:1209-1212
Published Date: 19 August 2013
Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
Kaneda A, Katagai T, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2013, 9:1203-1208
Published Date: 14 August 2013
Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers
Granieri A, Tamburello S, Tamburello A, Casale S, Cont C, Guglielmucci F, Innamorati M
Neuropsychiatric Disease and Treatment 2013, 9:1193-1202
Published Date: 14 August 2013
Temperamental characteristics in childhood migraine without aura: a multicenter study
Esposito M, Marotta R, Gallai B, Parisi L, Patriciello G, Lavano SM, Mazzotta G, Roccella M, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1187-1192
Published Date: 13 August 2013
Latent class analysis of reading, decoding, and writing performance using the Academic Performance Test: concurrent and discriminating validity
Cogo-Moreira H, Carvalho CAF, Kida ASB, de Avila CRB, Salum GA, Moriyama TS, Gadelha A, Rohde LA, Moura LM, Jackowski AP, Mari JJ
Neuropsychiatric Disease and Treatment 2013, 9:1175-1185
Published Date: 14 August 2013
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia
Nisijima K
Neuropsychiatric Disease and Treatment 2013, 9:1171-1174
Published Date: 12 August 2013
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
Olivares JM, Thirunavukarasu M, Kulkarni J, Zang HY, Zhang M, Zhang F
Neuropsychiatric Disease and Treatment 2013, 9:1163-1170
Published Date: 12 August 2013
A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients
Chen LF, Lin CE, Chou YC, Mao WC, Chen YC, Tzeng NS
Neuropsychiatric Disease and Treatment 2013, 9:1159-1162
Published Date: 9 August 2013
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
Gao K, Mackle M, Cazorla P, Zhao J, Szegedi A
Neuropsychiatric Disease and Treatment 2013, 9:1145-1157
Published Date: 22 August 2013
Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders
Bersani G, Polli E, Valeriani G, Zullo D, Melcore C, Capra E, Quartini A, Marino P, Minichino A, Bernabei L, Robiony M, Bersani FS, Liberati D
Neuropsychiatric Disease and Treatment 2013, 9:1137-1144
Published Date: 8 August 2013
Mental health system in Saudi Arabia: an overview
Qureshi NA, Al-Habeeb AA, Koenig HG
Neuropsychiatric Disease and Treatment 2013, 9:1121-1135
Published Date: 8 August 2013
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
Iasevoli F, Balletta R, Gilardi V, Giordano S, de Bartolomeis A
Neuropsychiatric Disease and Treatment 2013, 9:1113-1120
Published Date: 7 August 2013
Novel glutamatergic drugs for the treatment of mood disorders
Lapidus KAB, Soleimani L, Murrough JW
Neuropsychiatric Disease and Treatment 2013, 9:1101-1112
Published Date: 7 August 2013
Clinical features and imaging findings in a case of Capgras syndrome
Luca M, Bordone A, Luca A, Patti A, Sortino G, Calandra C
Neuropsychiatric Disease and Treatment 2013, 9:1095-1099
Published Date: 6 August 2013
Executive dysfunction in children affected by obstructive sleep apnea syndrome: an observational study
Esposito M, Antinolfi L, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Precenzano F, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1087-1094
Published Date: 9 August 2013
Intermittent hypoxia from obstructive sleep apnea may cause neuronal impairment and dysfunction in central nervous system: the potential roles played by microglia
Yang Q, Wang Y, Feng J, Cao J, Chen B
Neuropsychiatric Disease and Treatment 2013, 9:1077-1086
Published Date: 5 August 2013
The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease
McKinlay A, Albicini M, Kavanagh PS
Neuropsychiatric Disease and Treatment 2013, 9:1071-1076
Published Date: 6 August 2013
A case of early onset Parkinson's disease after major stress
Zou K, Guo W, Tang G, Zheng B, Zheng Z
Neuropsychiatric Disease and Treatment 2013, 9:1067-1069
Published Date: 2 August 2013
Self-concept evaluation and migraine without aura in childhood
Esposito M, Gallai B, Parisi L, Castaldo L, Marotta R, Lavano SM, Mazzotta G, Roccella M, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:1061-1066
Published Date: 5 August 2013
Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression
Sozeri-Varma G, Kalkan-Oguzhanoglu N, Efe M, Kiroglu Y, Duman T
Neuropsychiatric Disease and Treatment 2013, 9:1053-1059
Published Date: 12 August 2013
Shared decision making in psychiatric practice and the primary care setting is unique, as measured using a 9-item Shared Decision Making Questionnaire (SDM-Q-9)
De las Cuevas C, Peñate W, Perestelo-Pérez L, Serrano-Aguilar P
Neuropsychiatric Disease and Treatment 2013, 9:1045-1052
Published Date: 30 July 2013
Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
Zhang W, Wang Y, Cong SY, Nao JF, Feng J, Bi GR
Neuropsychiatric Disease and Treatment 2013, 9:1035-1043
Published Date: 30 July 2013
Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
Klimkowicz-Mrowiec A, Wolkow P, Sado M, Dziubek A, Pera J, Dziedzic T, Szczudlik A, Slowik A
Neuropsychiatric Disease and Treatment 2013, 9:1029-1033
Published Date: 29 July 2013
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis
Wu WT, Huang YH, Chen DC, Huang YH, Chou LW
Neuropsychiatric Disease and Treatment 2013, 9:1023-1028
Published Date: 29 July 2013
MicroRNA as therapeutic targets for treatment of depression
Hansen KF, Obrietan K
Neuropsychiatric Disease and Treatment 2013, 9:1011-1021
Published Date: 29 July 2013
Presurgical EEG-fMRI in a complex clinical case with seizure recurrence after epilepsy surgery
Zhang J, Liu Q, Mei S, Zhang X, Wang X, Liu W, Chen H, Xia H, Zhou Z, Li Y
Neuropsychiatric Disease and Treatment 2013, 9:1003-1010
Published Date: 26 July 2013
Age as a factor in sensory integration function in Taiwanese children
Lin CK, Wu HM, Wang HY, Tseng MH, Lin CH.
Neuropsychiatric Disease and Treatment 2013, 9:995-1001
Published Date: 25 July 2013
Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia
Kim JH, Ann JH, Lee J, Kim MH, Han AY
Neuropsychiatric Disease and Treatment 2013, 9:989-994
Published Date: 19 July 2013
The relationship between self-disgust, guilt, and flow experience among Japanese undergraduates
Hirao K, Kobayashi R
Neuropsychiatric Disease and Treatment 2013, 9:985-988
Published Date: 17 July 2013
Update on optimal use of lisdexamfetamine in the treatment of ADHD
Madaan V, Kolli V, Bestha DP, Shah MJ
Neuropsychiatric Disease and Treatment 2013, 9:977-983
Published Date: 22 July 2013
Current and emerging treatments for absence seizures in young patients
Vrielynck P
Neuropsychiatric Disease and Treatment 2013, 9:963-975
Published Date: 15 July 2013
Reduced dorsolateral prefrontal cortical hemodynamic response in adult obsessive-compulsive disorder as measured by near-infrared spectroscopy during the verbal fluency task
Hirosawa R, Narumoto J, Sakai Y, Nishida S, Ishida T, Nakamae T, Takei Y, Fukui K
Neuropsychiatric Disease and Treatment 2013, 9:955-962
Published Date: 11 July 2013
The efficacy of Li in bipolar disorder
Lozano R, Marín R, Santacruz MJ, Freire I, Gomez R
Neuropsychiatric Disease and Treatment 2013, 9:953-954
Published Date: 11 July 2013
Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment
Ozkan S, Adapinar DO, Elmaci NT, Arslantas D
Neuropsychiatric Disease and Treatment 2013, 9:947-951
Published Date: 9 July 2013
Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia
Suttajit S, Pilakanta S
Neuropsychiatric Disease and Treatment 2013, 9:941-946
Published Date: 9 July 2013
Acute parietal lobe infarction presenting as Gerstmann’s syndrome and cognitive decline mimicking senile dementia
Chen TY, Chen CY, Yen CH, Kuo SC, Yeh YW, Chang S, Huang SY
Neuropsychiatric Disease and Treatment 2013, 9:937-940
Published Date: 3 July 2013
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
Fereshtehnejad SM, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M
Neuropsychiatric Disease and Treatment 2013, 9:927-935
Published Date: 28 June 2013
Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children
Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Patriciello G, Precenzano F, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:921-926
Published Date: 26 June 2013
Is placebo useful in the treatment of major depression in clinical practice?
Marchesi C, De Panfilis C, Tonna M, Ossola P
Neuropsychiatric Disease and Treatment 2013, 9:915-920
Published Date: 25 June 2013
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M
Neuropsychiatric Disease and Treatment 2013, 9:893-914
Published Date: 24 June 2013
Pregabalin for the treatment of generalized anxiety disorder: an update
Baldwin DS, Ajel K, Masdrakis VG, Nowak M, Rafiq R
Neuropsychiatric Disease and Treatment 2013, 9:883-892
Published Date: 24 June 2013
Applicability of the Rivermead Behavioural Memory Test – Third Edition (RBMT-3) in Korsakoff's syndrome and chronic alcoholics
Wester AJ, van Herten JC, Egger JI, Kessels RP
Neuropsychiatric Disease and Treatment 2013, 9:875-881
Published Date: 21 June 2013
Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
Bae SO, Kim MD, Lee JG, Seo JS, Won SH, Woo YS, Seok JH, Kim W, Kim SJ, Min KJ, Jon DI, Shin YC, Bahk WM, Yoon BH
Neuropsychiatric Disease and Treatment 2013, 9:869-874
Published Date: 24 June 2013
Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
Washida K, Takeda T, Habara T, Sato S, Oka T, Tanaka M, Yoshimura Y, Aoki S
Neuropsychiatric Disease and Treatment 2013, 9:861-868
Published Date: 19 June 2013
Temporal changes in serum creatine kinase concentration and degree of muscle rigidity in 24 patients with neuroleptic malignant syndrome
Nisijima K, Shioda K
Neuropsychiatric Disease and Treatment 2013, 9:853-859
Published Date: 18 June 2013
Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases
Lasek-Bal A, Puz P, Kazibutowska Z
Neuropsychiatric Disease and Treatment 2013, 9:847-852
Published Date: 17 June 2013
A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania
Chen J, Lu Z, Zhang M, Zhang J, Ni X, Jiang X, Xu H, Heeramun-Aubeeluck A, Hu Q, Jin H, Davis JM
Neuropsychiatric Disease and Treatment 2013, 9:839-845
Published Date: 17 June 2013
Understanding the link between leadership style, employee satisfaction, and absenteeism: a mixed methods design study in a mental health care institution
Elshout R, Scherp E, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2013, 9:823-837
Published Date: 19 June 2013
Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia
Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Neuropsychiatric Disease and Treatment 2013, 9:815-822
Published Date: 14 June 2013
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Kamijima K, Hashimoto S, Nagayoshi E, Koyama T
Neuropsychiatric Disease and Treatment 2013, 9:813-814
Published Date: 5 June 2013
Balance and gait in older electroconvulsive therapy recipients: a pilot study
Plakiotis C, Barson F, Vengadasalam B, Haines TP, O'Connor DW
Neuropsychiatric Disease and Treatment 2013, 9:805-812
Published Date: 5 June 2013
Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study
Maneeton B, Maneeton N, Louthrenoo W
Neuropsychiatric Disease and Treatment 2013, 9:799-804
Published Date: 5 June 2013
The cost of schizophrenia in Japan
Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K
Neuropsychiatric Disease and Treatment 2013, 9:787-798
Published Date: 30 May 2013
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N
Neuropsychiatric Disease and Treatment 2013, 9:781-786
Published Date: 5 June 2013
Treatment in hospital for alcohol-dependent patients decreases attentional bias
Flaudias V, Brousse G, de Chazeron I, Planche F, Brun J, Llorca PM
Neuropsychiatric Disease and Treatment 2013, 9:773-779
Published Date: 30 May 2013
Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt
El Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Badry R, Metwally NA, El Moselhy EA, Hassan M, Sayed MA, Waris AA, Hamed Y, Shaaban I, Hamed MA, Kandil MR
Neuropsychiatric Disease and Treatment 2013, 9:767-771
Published Date: 27 May 2013
Psychomotor retardation and externally oriented thinking in major depression
Luca M, Luca A, Calandra C
Neuropsychiatric Disease and Treatment 2013, 9:759-766
Published Date: 27 May 2013
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
Warren CG, Dubovsky SL
Neuropsychiatric Disease and Treatment 2013, 9:753-758
Published Date: 24 May 2013
The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls
Bio DS, Soeiro-de-Souza MG, Otaduy MCG, Machado-Vieira R, Moreno RA
Neuropsychiatric Disease and Treatment 2013, 9:743-751
Published Date: 23 May 2013
Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports
Li CH, Chou MC, Liu CK, Lai CL
Neuropsychiatric Disease and Treatment 2013, 9:739-742
Published Date: 23 May 2013
A validation study of the Chinese-Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER)
Wong LL, Chan CC, Leung JL, Yung CY, Wu KK, Cheung SYY, Lam CLM
Neuropsychiatric Disease and Treatment 2013, 9:731-737
Published Date: 7 June 2013
Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose
Samtani MN, Nuamah I, Gopal S, Remmerie B, Sliwa JK, Alphs L
Neuropsychiatric Disease and Treatment 2013, 9:721-730
Published Date: 20 May 2013
Preventive treatment in migraine and the new US guidelines
Estemalik E, Tepper S
Neuropsychiatric Disease and Treatment 2013, 9:709-720
Published Date: 17 May 2013
Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-α and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats
Mohamed BMSA, Aboul-Fotouh S, Ibrahim EA, Shehata H, Mansour AA, Yassin NAZ, El-Eraky W, Abdel-Tawab AM
Neuropsychiatric Disease and Treatment 2013, 9:697-708
Published Date: 24 May 2013
Magnetic resonance spectroscopy in Alzheimer’s disease
Graff-Radford J, Kantarci K
Neuropsychiatric Disease and Treatment 2013, 9:687-696
Published Date: 16 May 2013
Reduced prefrontal cortex activation using the Trail Making Test in schizophrenia
Fujiki R, Morita K, Sato M, Kamada Y, Kato Y, Inoue M, Shoji Y, Uchimura N
Neuropsychiatric Disease and Treatment 2013, 9:675-685
Published Date: 16 May 2013
Epilepsy and homicide
Pandya NS, Vrbancic M, Ladino LD, Tellez-Zenteno JF
Neuropsychiatric Disease and Treatment 2013, 9:667-673
Published Date: 14 May 2013
Association between leptin and delirium in elderly inpatients
Sanchez JC, Ospina JP, Gonzalez MI
Neuropsychiatric Disease and Treatment 2013, 9:659-666
Published Date: 13 May 2013
Mood disorders and complementary and alternative medicine: a literature review
Qureshi NA, Al-Bedah AM
Neuropsychiatric Disease and Treatment 2013, 9:639-658
Published Date: 14 May 2013
Profile of perampanel and its potential in the treatment of partial onset seizures
Rheims S, Ryvlin P
Neuropsychiatric Disease and Treatment 2013, 9:629-637
Published Date: 13 May 2013
Differences between bipolar and unipolar depression on Rorschach testing
Kimura H, Osaki A, Kawashima R, Inoue T, Nakagawa S, Suzuki K, Asakura S, Tanaka T, Kitaichi Y, Masui T, Kitagawa N, Kako Y, Abekawa T, Kusumi I, Yamanaka H, Denda K, Koyama T
Neuropsychiatric Disease and Treatment 2013, 9:619-627
Published Date: 7 May 2013
Assessing public speaking fear with the short form of the Personal Report of Confidence as a Speaker scale: confirmatory factor analyses among a French-speaking community sample
Heeren A, Ceschi G, Valentiner DP, Dethier V, Philippot P
Neuropsychiatric Disease and Treatment 2013, 9:609-618
Published Date: 3 May 2013
Effectively managing intractable central hyperthermia in a stroke patient by bromocriptine: a case report
Yu KW, Huang YH, Lin CL, Hong CZ, Chou LW
Neuropsychiatric Disease and Treatment 2013, 9:605-608
Published Date: 3 May 2013
Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia
Battaglia G, Alesi M, Inguglia M, Roccella M, Caramazza G, Bellafiore M, Palma A
Neuropsychiatric Disease and Treatment 2013, 9:595-603
Published Date: 3 May 2013
Profile of blonanserin for the treatment of schizophrenia
Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N
Neuropsychiatric Disease and Treatment 2013, 9:587-594
Published Date: 29 April 2013
Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease
Kato Y, Narumoto J, Matsuoka T, Okamura A, Koumi H, Kishikawa Y, Terashima S, Fukui K
Neuropsychiatric Disease and Treatment 2013, 9:581-586
Published Date: 30 April 2013
Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
Zhang L, Wang G, Luo J, Zhang QE, Zhao Q, Deng QY, Ma X
Neuropsychiatric Disease and Treatment 2013, 9:575-580
Published Date: 26 April 2013
Mitochondrial dysfunction, oxidative stress, and major depressive disorder
Tobe EH
Neuropsychiatric Disease and Treatment 2013, 9:567-573
Published Date: 26 April 2013
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
Kamijima K, Hashimoto S, Nagayoshi E, Koyama T
Neuropsychiatric Disease and Treatment 2013, 9:555-565
Published Date: 26 April 2013
Role of oral teriflunomide in the management of multiple sclerosis
Tanasescu R, Evangelou N, Constantinescu CS
Neuropsychiatric Disease and Treatment 2013, 9:539-553
Published Date: 22 April 2013
Blended E-health module on return to work embedded in collaborative occupational health care for common mental disorders: design of a cluster randomized controlled trial
Volker D, Vlasveld MC, Anema JR, Beekman ATF, Hakkaart-van Roijen L, Brouwers EPM, van Lomwel AGC, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2013, 9:529-537
Published Date: 22 April 2013
Predicting PTSD using the New York Risk Score with genotype data: potential clinical and research opportunities
Boscarino JA, Kirchner HL, Hoffman SN, Erlich PM
Neuropsychiatric Disease and Treatment 2013, 9:517-527
Published Date: 15 April 2013
Psychosurgery for schizophrenia: history and perspectives
Soares MS, Paiva WS, Guertzenstein EZ, Amorim RL, Bernardo LS, Pereira JF, Fonoff ET, Teixeira MJ
Neuropsychiatric Disease and Treatment 2013, 9:509-515
Published Date: 15 April 2013
Worsened hypertension control induced by aripiprazole
Yasui-Furukori N, Fujii A
Neuropsychiatric Disease and Treatment 2013, 9:505-507
Published Date: 15 April 2013
Transcranial magnetic stimulation for treating depression in elderly patients
Hizli Sayar G, Ozten E, Tan O, Tarhan N
Neuropsychiatric Disease and Treatment 2013, 9:501-504
Published Date: 15 April 2013
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
Diniz BS, Machado Vieira R, Forlenza OV
Neuropsychiatric Disease and Treatment 2013, 9:493-500
Published Date: 12 April 2013
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
Gabriel A
Neuropsychiatric Disease and Treatment 2013, 9:485-492
Published Date: 12 April 2013
Effects of primary caregiver participation in vestibular rehabilitation for unilateral neglect patients with right hemispheric stroke: a randomized controlled trial
Dai CY, Huang YH, Chou LW, Wu SC, Wang RY, Lin LC
Neuropsychiatric Disease and Treatment 2013, 9:477-484
Published Date: 8 April 2013
Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline
Delgado Nunes V, Sawyer L, Neilson J, Sarri G, Cross JH
Neuropsychiatric Disease and Treatment 2013, 9:467-476
Published Date: 8 April 2013
Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
Penders TM, Agarwal S, Rohaidy RV
Neuropsychiatric Disease and Treatment 2013, 9:463-465
Published Date: 4 April 2013
Maturation of the adolescent brain
Arain M, Haque M, Johal L, Mathur P, Nel W, Rais A, Sandhu R, Sharma S
Neuropsychiatric Disease and Treatment 2013, 9:449-461
Published Date: 3 April 2013
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature
Hsieh PC, Chen SM, Guo YH, Kuan TS, Yen WJ, Chang WC, Lin YC
Neuropsychiatric Disease and Treatment 2013, 9:445-448
Published Date: 4 April 2013
Primary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter study
Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:437-443
Published Date: 31 March 2013
Two diagnoses become one? Rare case report of anorexia nervosa and Cushing’s syndrome
Sawicka N, Gryczyńska M, Sowiński J, Tamborska-Zedlewska M, Ruchała M
Neuropsychiatric Disease and Treatment 2013, 9:431-435
Published Date: 31 March 2013
Neuropsychology of eating disorders: 1995–2012
Jáuregui-Lobera I
Neuropsychiatric Disease and Treatment 2013, 9:415-430
Published Date: 31 March 2013
Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis
Cazorla P, Zhao J, Mackle M, Szegedi A
Neuropsychiatric Disease and Treatment 2013, 9:409-413
Published Date: 28 March 2013
Impact of nocturnal sleep deprivation on declarative memory retrieval in students at an orphanage: a psychoneuroradiological study
Tantawy AO, El Tallawy HN, Farghaly HRS, Farghaly WM, Hussein AS
Neuropsychiatric Disease and Treatment 2013, 9:403-408
Published Date: 27 March 2013
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
Chen SJ, Chang CH, Tsai HC, Chen ST, Lin CC
Neuropsychiatric Disease and Treatment 2013, 9:397-401
Published Date: 26 March 2013
Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses
Assogna F, Fagioli S, Cravello L, Meco G, Pierantozzi M, Stefani A, Imperiale F, Caltagirone C, Pontieri FE, Spalletta G
Neuropsychiatric Disease and Treatment 2013, 9:389-396
Published Date: 21 March 2013
Personality disorders and treatment drop out in the homeless
Salavera C, Tricás JM, Lucha O
Neuropsychiatric Disease and Treatment 2013, 9:379-387
Published Date: 22 March 2013
A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
Bodén R, Edman G, Reutfors J, Östenson CG, Ösby U
Neuropsychiatric Disease and Treatment 2013, 9:371-377
Published Date: 19 March 2013
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
Jara M, Barker G, Henney 3rd HR
Neuropsychiatric Disease and Treatment 2013, 9:365-370
Published Date: 10 March 2013
Treatment in a ward for elderly patients with dementia in Japan
Taniguchi S, Narumoto J, Shibata K, Ayani N, Matsuoka T, Okamura A, Nakamura K, Shimizu H, Fukui K
Neuropsychiatric Disease and Treatment 2013, 9:357-363
Published Date: 6 March 2013
Maternal stress and childhood migraine: a new perspective on management
Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Gritti A, Mazzotta G, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:351-355
Published Date: 6 March 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
Alphs L, Bossie CA, Sliwa JK, Fu DJ, Ma YW, Hulihan J
Neuropsychiatric Disease and Treatment 2013, 9:341-350
Published Date: 5 March 2013
Review: management of Parkinson's disease
Pedrosa DJ, Timmermann L
Neuropsychiatric Disease and Treatment 2013, 9:321-340
Published Date: 3 March 2013
Interaction between paliperidone extended release and TS-1®, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
Yasui-Furukori N, Hashimoto K, Kubo K, Tomita T
Neuropsychiatric Disease and Treatment 2013, 9:317-320
Published Date: 3 March 2013
Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy
Prazeres AM, Nascimento AL, Fontenelle LF
Neuropsychiatric Disease and Treatment 2013, 9:307-316
Published Date: 28 February 2013
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
Cormier J, Chu CJ
Neuropsychiatric Disease and Treatment 2013, 9:295-306
Published Date: 21 February 2013
Hypersomnia in children affected by migraine without aura: a questionnaire-based case-control study
Esposito M, Roccella M, Parisi L, Gallai B, Carotenuto M
Neuropsychiatric Disease and Treatment 2013, 9:289-294
Published Date: 21 February 2013
Postpartum depression: psychoneuroimmunological underpinnings and treatment
Anderson G, Maes M
Neuropsychiatric Disease and Treatment 2013, 9:277-287
Published Date: 21 February 2013
Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors
Kawaguchi A, Watanabe N, Nakano Y, Ogawa S, Suzuki M, Kondo M, Furukawa TA, Akechi T
Neuropsychiatric Disease and Treatment 2013, 9:267-275
Published Date: 20 February 2013
Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil
Kano O, Ito H, Takazawa T, Kawase Y, Murata K, Iwamoto K, Nagaoka T, Hirayama T, Miura K, Nagata R, Kiyozuka T, Aoyagi J, Sato R, Eguchi T, Ikeda K, Iwasaki Y
Neuropsychiatric Disease and Treatment 2013, 9:259-265
Published Date: 15 February 2013
Inpatient rehabilitation outcome: a matter of diagnosis?
Bejor M, Ramella FC, Dalla Toffola E, Comelli M, Chiappedi M
Neuropsychiatric Disease and Treatment 2013, 9:253-257
Published Date: 18 February 2013
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P
Neuropsychiatric Disease and Treatment 2013, 9:243-251
Published Date: 15 February 2013
Mental health in migrant schoolchildren in Italy: teacher-reported behavior and emotional problems
Margari L, Pinto F, Lafortezza ME, Lecce PA, Craig F, Grattagliano I, Zagaria G, Margari F
Neuropsychiatric Disease and Treatment 2013, 9:231-241
Published Date: 11 February 2013
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
Ermer J, Haffey MB, Richards C, Lasseter K, Adeyi B, Corcoran M, Stanton B, Martin P
Neuropsychiatric Disease and Treatment 2013, 9:219-229
Published Date: 12 February 2013
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
Valdizán-Usón JR, Cánovas-Martínez A, De Lucas-Taracena M, Díaz-Atienza F, Eddy-Ives LS, Fernández-Jaén A, Fernández-Pérez M, García-Giral M, García-Magán P, Garraus-Oneca M, Idiazábal-Alecha MA, López-Benito M, Lorenzo-Sanz G, Martínez-Antón J, Martínez-Granero MA, Montañés-Rada F, Mulas-Delgado F, Ochando-Perales G, Ortega-García E, Pelaz-Antolín A, Ramos-Quiroga JA, Ruiz-Sanz FC, Vaquerizo-Madrid J, Yusta-Izquierdo A
Neuropsychiatric Disease and Treatment 2013, 9:211-218
Published Date: 8 February 2013
Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
Dell'Osso B, Arici C, Dobrea C, Camuri G, Benatti B, Altamura AC
Neuropsychiatric Disease and Treatment 2013, 9:205-209
Published Date: 8 February 2013
Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
Jeong JH, Bahk WM, Woo YS, Seo HJ, Hong SC, Jon DI, Min KJ, Yoon BH
Neuropsychiatric Disease and Treatment 2013, 9:197-204
Published Date: 8 February 2013
Editor’s choice: the best of 2011–2012
Pinder RM
Neuropsychiatric Disease and Treatment 2013, 9:195-196
Published Date: 8 February 2013
The relationship between alexithymia, shame, trauma, and body image disorders: investigation over a large clinical sample
Franzoni E, Gualandi S, Caretti V, Schimmenti A, Di Pietro E, Pellegrini G, Craparo G, Franchi A, Verrotti A, Pellicciari A
Neuropsychiatric Disease and Treatment 2013, 9:185-193
Published Date: 18 February 2013
Semantics, pragmatics, and formal thought disorders in people with schizophrenia
Salavera C, Puyuelo M, Antoñanzas JL, Teruel P
Neuropsychiatric Disease and Treatment 2013, 9:177-183
Published Date: 7 February 2013
Epidemiology and treatment of mood disorders in a day hospital setting from 1996 to 2007: an Italian study
Luca M, Prossimo G, Messina V, Luca A, Romeo S, Calandra C
Neuropsychiatric Disease and Treatment 2013, 9:169-176
Published Date: 7 February 2013
General versus executive cognitive ability in pupils with ADHD and with milder attention problems
Ek U, Westerlund J, Fernell E
Neuropsychiatric Disease and Treatment 2013, 9:163-168
Published Date: 29 January 2013
Acupressure therapy for insomnia in adolescents: a polysomnographic study
Carotenuto M, Gallai B, Parisi L, Roccella M, Esposito M
Neuropsychiatric Disease and Treatment 2013, 9:157-162
Published Date: 24 January 2013
Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae
Okamoto H, Chino A, Hirasaki Y, Ueda K, Iyo M, Namiki T
Neuropsychiatric Disease and Treatment 2013, 9:151-155
Published Date: 18 January 2013
A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
Baskaran A, Milev R, McIntyre RS
Neuropsychiatric Disease and Treatment 2013, 9:143-150
Published Date: 17 January 2013
Capgras-like syndrome in a patient with an acute urinary tract infection
Salviati M, Bersani FS, Macrì F, Fojanesi M, Minichino A, Gallo M, De Michele F, Delle Chiaie R, Biondi M
Neuropsychiatric Disease and Treatment 2013, 9:139-142
Published Date: 17 January 2013
Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia
Gordon PC, Xavier JC, Louzã MR
Neuropsychiatric Disease and Treatment 2013, 9:133-138
Published Date: 17 January 2013
Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
Medic G, Higashi K, Littlewood KJ, Diez T, Granström O, Kahn RS
Neuropsychiatric Disease and Treatment 2013, 9:119-131
Published Date: 16 January 2013
Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia
Suttajit S, Srisurapanont M, Pilakanta S, Charnsil C, Suttajit S.
Neuropsychiatric Disease and Treatment 2013, 9:113-118
Published Date: 16 January 2013
A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
Tränkner A, Sander C, Schönknecht P
Neuropsychiatric Disease and Treatment 2013, 9:101-111
Published Date: 18 January 2013
Easy quantitative methodology to assess visual-motor skills
Chiappedi M, Toraldo A, Mandrini S, Scarpina F, Aquino M, Magnani FG, Bejor M
Neuropsychiatric Disease and Treatment 2013, 9:93-100
Published Date: 14 January 2013
Sensory integration dysfunction affects efficacy of speech therapy on children with functional articulation disorders
Tung LC, Lin CK, Hsieh CL, Chen CC, Huang CT, Wang CH
Neuropsychiatric Disease and Treatment 2013, 9:87-92
Published Date: 9 January 2013
Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy
Guidotti M, Barrilà C, Leva S, De Piazza C, Omboni S
Neuropsychiatric Disease and Treatment 2013, 9:81-85
Published Date: 16 January 2013
Differential attentional bias in generalized anxiety disorder and panic disorder
Chen J, Wang Z, Wu Y, Cai Y, Shen Y, Wang L, Shi S
Neuropsychiatric Disease and Treatment 2013, 9:73-80
Published Date: 8 January 2013
Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome
Gürsoy AE, Kolukısa M, Babacan Yıldız G, Kocaman G, Çelebi A, Koçer A
Neuropsychiatric Disease and Treatment 2013, 9:65-71
Published Date: 7 January 2013
A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion
Sánchez-Ferro A, Benito-León J, Mitchell AJ, Bermejo-Pareja F
Neuropsychiatric Disease and Treatment 2013, 9:55-63
Published Date: 4 January 2013
Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
Kimura T, Takamatsu J
Neuropsychiatric Disease and Treatment 2013, 9:49-53
Published Date: 28 December 2012
Self-reported psychopathology and health-related quality of life in heroin users treated with methadone
Chen YZ, Huang WL, Shan JC, Lin YH, Wu Chang HC, Chang LR
Neuropsychiatric Disease and Treatment 2013, 9:41-48
Published Date: 27 December 2012
Effects, experiences, and impact of stigma on patients with bipolar disorder
Mileva VR, Vázquez GH, Milev R
Neuropsychiatric Disease and Treatment 2013, 9:31-40
Published Date: 16 January 2013
Decreased white matter integrity before the onset of delusions in patients with Alzheimer's disease: diffusion tensor imaging
Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M
Neuropsychiatric Disease and Treatment 2013, 9:25-29
Published Date: 27 December 2012
Predictors of postpartum depression in a sample of Egyptian women
Saleh ES, El-Bahei W, El-Hadidy MA, Zayed A
Neuropsychiatric Disease and Treatment 2013, 9:15-24
Published Date: 21 December 2012
Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot study
Sato J, Nakaaki S, Torii K, Oka M, Negi A, Tatsumi H, Narumoto J, Furukawa TA, Mimura M
Neuropsychiatric Disease and Treatment 2013, 9:9-14
Published Date: 21 December 2012
Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer’s disease: a voxel-based morphometry study
Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M
Neuropsychiatric Disease and Treatment 2013, 9:1-8
Published Date: 21 December 2012